The long term objective of this proposal is the generation of a mouse model for cystic fibrosis (CF). Mutations known to cause CF in humans will be introduced into the murine CFTR gene of pluripotent embryonic stem (ES) cells. Mouse lines will be derived from ES cells carrying these mutations and evaluated for the presence of disease similar to that characteristic of CF in humans. The extent to which the pathophysiology of the disease in mice mimics that in humans will define whether the mouse model will be useful for testing therapeutic protocols, including gene therapy. We have six specific aims: 1. We will generate a mouse line carrying a CFTR gene in which a termination codon has been introduced into exon 10 by gene targeting. 2. We will generate a mouse line carrying the most common mutation found in human CF patients, the deletion of three bases in exon 10. 3. We will generate mice carrying the A117H mutation in exon 4, which is known to result in a mild form of CF in humans. 4. During the course of generating these three animals we will define factors which affect the targeting of DNA to the CFTR locus. 5. We will generate mice in which the expression of the CFTR gene can be detected with a chromogenic assay to assist in the analysis of disease in these animals. 6. We will evaluate the disease caused by the three CFTR mutations to determine whether the initiation and progression of the disease are similar to those in humans. This will determine to what extent these animals can be used for in vivo analysis of the pathophysiology of CF and for testing new approaches to the treatment of CF.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK046003-05
Application #
2016618
Study Section
Special Emphasis Panel (SRC (MP))
Project Start
1992-09-30
Project End
1998-09-29
Budget Start
1996-09-30
Budget End
1998-09-29
Support Year
5
Fiscal Year
1996
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Goldsmith, Elizabeth J; Min, Xiaoshan; He, Haixia et al. (2010) Structural studies of MAP Kinase cascade components. Methods Mol Biol 661:223-37
Grubb, B R (1997) Ion transport across the murine intestine in the absence and presence of CFTR. Comp Biochem Physiol A Physiol 118:277-82
Goulet, J L; Wang, C Y; Koller, B H (1997) Embryonic stem cell lines from MRL mice allow genetic modification in a murine model of autoimmune disease. J Immunol 159:4376-81
Grubb, B R; Boucher, R C (1997) Enhanced colonic Na+ absorption in cystic fibrosis mice versus normal mice. Am J Physiol 272:G393-400
Byrum, R S; Goulet, J L; Griffiths, R J et al. (1997) Role of the 5-lipoxygenase-activating protein (FLAP) in murine acute inflammatory responses. J Exp Med 185:1065-75
Dombrowicz, D; Brini, A T; Flamand, V et al. (1996) Anaphylaxis mediated through a humanized high affinity IgE receptor. J Immunol 157:1645-51
Gowen, L C; Johnson, B L; Latour, A M et al. (1996) Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat Genet 12:191-4
Bozza, P T; Payne, J L; Goulet, J L et al. (1996) Mechanisms of platelet-activating factor-induced lipid body formation: requisite roles for 5-lipoxygenase and de novo protein synthesis in the compartmentalization of neutrophil lipids. J Exp Med 183:1515-25
Leung, A Y; Wong, P Y; Gabriel, S E et al. (1995) cAMP- but not Ca(2+)-regulated Cl- conductance in the oviduct is defective in mouse model of cystic fibrosis. Am J Physiol 268:C708-12
Grubb, B R (1995) Ion transport across the jejunum in normal and cystic fibrosis mice. Am J Physiol 268:G505-13

Showing the most recent 10 out of 16 publications